Italy: Chiesi Group expanding global Rare Disease portfolio with US$1.9bn acquisition of KalVista

Chiesi Group, an Italy-based, family-controlled, international research-focused biopharmaceutical group and certified B Corp, is acquiring Nasdaq-listed KalVista Pharmaceuticals, a global pharmaceutical company focused on...

France: Stago accelerating growth with Archimed and La Caisse

Archimed Diagnostics – the diagnostics team of France‑based global healthcare private equity specialist Archimed – has acquired Stago, a world leader in haemostasis analysis....

Iceland: NIB finances nursing home and healthcare facilities in Reykjavik 

NIB, the international financial institution of Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Norway, and Sweden, has signed an ISK4.4bn (US$36m) 10-year indexed loan with the listed Icelandic...

Switzerland: vVardis reaches unicorn status following investment from Apollo

vVardis Holding, a Switzerland-based dental medtech company pioneering non-invasive cavity treatment, has achieved unicorn status following a strategic minority investment from US-based Apollo-managed funds....

France: Echosens appoints Romain Baujard as group CEO

Echosens, a France-based specialist diagnostic company providing non-invasive medical devices and services to support physicians in their diagnostic and monitoring of chronic liver diseases,...

Namibia: Salt Capital and Proparco acquire The Namibian Oncology Centre

Salt Capital, a private equity investment firm focused on growth capital investments in the SADC region, and Proparco, the French Development finance institution, have...

UK: Allica Bank expands lending and products in support of healthcare businesses

UK-based business challenger bank, Allica Bank, is announced it is expanding its lending and product flexibility in support of UK healthcare operators. The changes...

Luxembourg: Astorg to acquire Thermo Fisher Scientific’s microbiology business for US$1.075bn

Astorg, a pan European private equity firm, has signed a definitive agreement to acquire New York-listed Thermo Fisher Scientific’s microbiology business for approximately US$1.075bn,...

France: Servier acquires Day One Bio for US$2.5bn

France-headquartered Servier, an independent international pharmaceutical group governed by a foundation, has acquired Nasdaq-listed Day One Biopharmaceuticals, a biopharmaceutical company developing and commercialising targeted...

Netherlands: Waterland raises €4.6bn in less than four months

Netherlands-based independent PE investment group, Waterland, has announced the closing of its 10th institutional flagship fund Waterland Private Equity Fund X (WPEF X) at €4bn...
Advertisement